1 / 10

Vaccines and HIV Testing Conference Overview

Learn about HPV and influenza vaccines, expanded HIV testing, and associated issues such as access, cost, and mandates. Important guidelines and actions discussed by experts.

plato-larsen
Télécharger la présentation

Vaccines and HIV Testing Conference Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Issues Related to Vaccines and HIV Testing Annual Family Conference ACES October 11, 2007 Charles H. Woernle, MD, MPH Alabama Department of Public Health

  2. Topics • Issues related to vaccines • Human papillomavirus vaccine • Influenza vaccine • Expanded testing for human immunodeficiency virus (HIV)

  3. Immunization Issues • Vaccines—most effective measure to prevent disease • Four related issues: • Acceptance • Access • Cost • Mandates

  4. Human Papillomavirus Vaccine • Prevents infection from 4 types of HPV • Two types cause 90% of genital warts • Two types cause 70% of cervical cancers • Vaccine recommended for females 9-26 years of age

  5. Issues related to HPV Vaccine • Cost • ~$300 vaccine cost for the 3-dose series • Policy • Societal acceptance—vaccine must be given before onset of sexual activity • Question of mandated vaccination

  6. Objective 4.12 • Increase to 90 percent or more influenza immunization coverage among adults aged 65 years or older • AL baseline (1997) = 62% • US baseline (1995) = 58% • AL 2006 = 62% • US 2006 = 69%

  7. Visit www.adph.org/publications

  8. Expanded HIV Testing • ~25% of HIV-infected persons do not know they are infected; delay results in • Illness • Spread of infection • September 2006 CDC guidelines • Offer HIV testing routinely in clinic settings • “Opt out” instead of “opt in”

  9. ADPH Actions • Modifying informed consent to include reference to HIV as a routine test • Modifying HIV laboratory requisition slip • Suitable for use in both clinic settings and HIV counseling and testing sites • Dual approach • Individualized consent and pre-test counseling in non-clinical settings • Routine testing in clinical settings

  10. Post-test Counseling • Tested individuals should be informed of their results • Persons with positive results need to be referred for services

More Related